Viewing Study NCT06780592


Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2025-12-24 @ 3:36 PM
Study NCT ID: NCT06780592
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-22
First Post: 2025-01-13
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery
Sponsor: Huashan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module